Zynlonta

loncastuximab tesirine-lpyl

Approval

ApplicationBLA 761196
Approval dateApr 23, 2021
Approval year2021
SponsorADC Therapeutics SA

FDA-approved use

To treat certain types of relapsed or refractory large B-cell lymphoma

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Zynlonta: